title: Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy.
authors.affiliation: Dementia Research Centre, Department of Neurodegeneration, Institute of Neurology, Queen Square, London WC1N3BG, United Kingdom. Electronic address: r.paterson@ucl.ac.uk.
authors.forename: Ross W
authors.initials: RW
authors.lastname: Paterson
authors.affiliation: Dementia Research Centre, Department of Neurodegeneration, Institute of Neurology, Queen Square, London WC1N3BG, United Kingdom. Electronic address: z.abdi@ucl.ac.uk.
authors.forename: Zeinab
authors.initials: Z
authors.lastname: Abdi
authors.affiliation: Dementia Research Centre, Department of Neurodegeneration, Institute of Neurology, Queen Square, London WC1N3BG, United Kingdom.
authors.forename: Amanda
authors.initials: A
authors.lastname: Haines
authors.affiliation: Dementia Research Centre, Department of Neurodegeneration, Institute of Neurology, Queen Square, London WC1N3BG, United Kingdom. Electronic address: j.schott@ucl.ac.uk.
authors.forename: Jonathan M
authors.initials: JM
authors.lastname: Schott
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D016657:Cerebral Amyloid Angiopathy / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D016896:Treatment Outcome
chemical_list: D002800:Cholinesterase Inhibitors
keywords: Acetyl-cholinesterase inhibitor; Alzheimer’s disease; Amyloid spells; Boston criteria; Cerebral amyloid angiopathy; Leukoaraiosis; Microhaemorrhage; Stroke